跳到正文
原文
Medical Xpress·· 2026-10-08精选AI 评分72

Nature 研究:内置免疫系统的肺类器官模型揭示局部抗病毒 T 细胞反应

Human lung organoids with a built-in immune system could transform respiratory disease research

AI 导读

斯坦福大学医学院团队在 Nature 发表研究,构建了源自人类肺组织的类器官模型,发现其可长期维持组织驻留 T 细胞并产生病毒特异性免疫反应。研究人员进一步证实,预先暴露于病毒抗原可增强该模型对 SARS-CoV-2 后续感染的抵抗力,表明肺黏膜局部免疫系统在防御呼吸道病原体中发挥独立作用。该模型可能作为部分动物实验的替代平台,并为评估局部疫苗策略及研究慢性阻塞性肺疾病、哮喘等肺部疾病提供新工具。

推荐理由

研究展示了肺类器官可维持病毒特异性免疫记忆,读者可评估其在肺部疫苗研发中的应用潜力。

正文 · 原文
Human lung organoids with a built-in immune system could transform respiratory disease research
Characterization of suspension lung organoid culture. Credit: Nature (2026). DOI: 10.1038/s41586-026-11114-1

A new organoid model built with human lung fragments may help us answer key questions about one of the body's first lines of defense against respiratory pathogens. In a new study, researchers at the Stanford University School of Medicine elicited virus-specific immune responses from these organoids and showed that administering a virus booster weakened subsequent infections.

The findings suggest the lung mucosa's immune system alone may provide significant protection, adding to growing evidence that vaccination strategies designed to train the body's frontline defenses are a worthwhile pursuit. The models may also be ideal testing grounds for such interventions.

"These organoids retain key immune cells and functions of lung mucosa long term, allowing investigators to examine local tissue immunity separately from the other parts of the body's immune system," said John H. Powers III, M.D., acting director of NIH's National Institute of Allergy and Infectious Diseases (NIAID). "This platform may provide a replacement for animal models for some types of evaluations and may provide insights that tests in animal models could not capture."

Lung tissue retains virus-specific defenses

For the new study, published in Nature, the researchers transferred pieces of intact distal lung tissue from more than 220 patient volunteers into a unique cell culture system that simulated the lung's life-sustaining gas exchange. The authors sustained organoids within this 3D air-liquid interface for up to several months, during which they found many critical immune cell populations thriving. More specifically, they confirmed that the T cells present were permanent residents of the tissue and maintained their virus-sensing capabilities.

With these components of the immune system present in the model, the team next sought to determine whether it was also fully functional. Infecting organoids with SARS-CoV-2, the researchers saw that the lung models countered with not only generic immune reactions such as inflammation but also adaptive responses, as T cells became reactive to SARS-CoV-2 specifically.

They also tested the impact of prestimulating the organoids with fragments of the virus before infection, essentially simulating a kind of vaccination. Again, the organoids' immune cells learned how to better detect and dispatch SARS-CoV-2, which diminished future infections.

"The exact role of local immunity in human lungs has long been a hotly debated subject, but we believe these organoids will be a conduit for clear answers. Already, we've unveiled indications that resident T cells may be much more persistent than previously thought," said corresponding author Calvin Kuo, M.D., Ph.D., a professor of hematology at Stanford Medicine.

Local vaccines and wider disease research

The authors believe that their findings and future work in these models could provide a strong basis for local vaccination, which may complement or replace traditional vaccines that induce adaptive immunity systemically.

Their scope may also widen greatly in the future. The researchers believe their models could potentially help elucidate the role of tissue-resident immune responses in a variety of other pulmonary diseases, such as chronic obstructive pulmonary disease (COPD), asthma and bacterial infections.

Publication details

Joseph K. Rathkey et al, Human lung organoid modelling of tissue-resident antiviral T cell responses, Nature (2026). DOI: 10.1038/s41586-026-11114-1

Journal information: Nature

Key medical concepts

OrganoidsSARS-CoV-2

Who's behind this story?

Lisa Lock

Lisa Lock

BA art history, MA material culture. Former museum editor, paramedic, and transplant coordinator. Editing for Science X since 2021. Full profile →

Robert Egan

Robert Egan

Bachelor's in mathematical biology, Master's in creative writing. Well-traveled with unique perspectives on science and language. Full profile →

Citation: Human lung organoids with a built-in immune system could transform respiratory disease research (2026, October 7) retrieved 7 October 2026 from https://medicalxpress.com/news/2026-10-human-lung-organoids-built-immune.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

来源:Medical Xpress · medicalxpress.com